Who Owns Gilead Sciences Stock?
NASDAQ: GILDHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
At close: Oct 8, 4:00 PM ET · Delayed 15 min
Ownership breakdown
- Held by institutions
- 92.20%
- Held by insiders
- 0.11%
- Institutional holders
- 3,078
- Institutions 92.2%
- Insiders 0.1%
- Public and other 7.7%
Who owns Gilead Sciences stock?
Institutional investors own about 92.2% of Gilead Sciences's shares, spread across 3,078 institutions that file 13F reports. That level of institutional ownership is high, typical of large, widely followed companies. Insiders, including executives, directors and large founding shareholders, hold 0.11% of GILD.
The largest institutional holders are Blackrock Inc. (9.83%), Vanguard Capital Management LLC (6.54%) and FMR, LLC (5.39%). Together, the top 10 institutions control 42.9% of shares outstanding. In their latest filings, 7 of the top 10 institutions increased their GILD positions and 3 reduced them.
Summary generated from market data by MetaCap's automated system. Methodology
Top institutional holders of GILD
| Institution | Shares | % Held | Change |
|---|---|---|---|
| Blackrock Inc. | 121.84M | 9.83% | +2.4% |
| Vanguard Capital Management LLC | 81.09M | 6.54% | +0.5% |
| FMR, LLC | 66.87M | 5.39% | -7.0% |
| State Street Corporation | 61.22M | 4.94% | +2.3% |
| Capital World Investors | 40.99M | 3.31% | -0.7% |
| Invesco Ltd. | 39.82M | 3.21% | -4.2% |
| Vanguard Portfolio Management LLC | 35.32M | 2.85% | +0.5% |
| Geode Capital Management, LLC | 30.07M | 2.42% | +1.1% |
| Price (T.Rowe) Associates Inc | 30.00M | 2.42% | +14.3% |
| Morgan Stanley | 24.00M | 1.94% | +3.0% |
% held is the share of total shares outstanding. Change is the percentage change in the position since the holder's previous 13F filing.
Top mutual fund and ETF holders of GILD
| Fund | Shares | % Held |
|---|---|---|
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 39.42M | 3.18% |
| VANGUARD INDEX FUNDS-Vanguard 500 Index Fund | 32.17M | 2.59% |
| Invesco QQQ Trust, Series 1 | 26.71M | 2.15% |
| Dodge & Cox Funds-Dodge & Cox Stock Fund | 17.28M | 1.39% |
| iShares Trust-iShares Core S&P 500 ETF | 16.53M | 1.33% |
| Fidelity Concord Street Trust-Fidelity 500 Index Fund | 16.12M | 1.30% |
| Income Fund of America | 15.50M | 1.25% |
| SPDR S&P 500 ETF TRUST-State Street SPDR S&P 500 ETF Trust | 15.19M | 1.22% |
| VANGUARD INDEX FUNDS-Vanguard Value Index Fund | 11.82M | 0.95% |
| WASHINGTON MUTUAL INVESTORS FUND | 10.31M | 0.83% |
Frequently asked questions
Who is the largest shareholder of Gilead Sciences?
Blackrock Inc. is the largest institutional shareholder of GILD, owning 9.83% of shares outstanding (121.84M shares) as of its latest 13F filing.
What percentage of Gilead Sciences is owned by institutions?
Institutions own about 92.2% of GILD shares and 92.3% of the public float.
How much of Gilead Sciences do insiders own?
Insiders, such as officers and directors, own about 0.11% of GILD shares outstanding.
Where does institutional ownership data come from?
Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.